These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20180410)

  • 1. [Testosterone undecanoate for late -onset hypogonadism: an update].
    Fan XB; Huang YF
    Zhonghua Nan Ke Xue; 2010 Jan; 16(1):68-71. PubMed ID: 20180410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose testosterone undecanoate capsules combined with tadalafil for late-onset hypogonadism accompanied with ED].
    Li GY; Liang JH; Meng ZB; Huang CC; Liang SK; Wei GQ; Shen SL; Zhu CH; Zhang X; Song WR
    Zhonghua Nan Ke Xue; 2013 Jul; 19(7):630-3. PubMed ID: 23926681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tadalafil improves total testosterone, IIEF score and SEP in old and middle-aged males with late-onset hypogonadism].
    Wang XK; Luo L; Wang S; Li J; Li WX
    Zhonghua Nan Ke Xue; 2012 May; 18(5):475-7. PubMed ID: 22741450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile dysfunction and hypogonadism (low testosterone).
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():2-7. PubMed ID: 21501544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism].
    Mazo EB; Gamidov SI; Sotnikova EM
    Ter Arkh; 2008; 80(12):59-63. PubMed ID: 19227909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
    Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of testosterone in the treatment of erectile dysfunction.
    Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
    Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and erectile physiology.
    Guay AT
    Aging Male; 2006 Dec; 9(4):201-6. PubMed ID: 17178555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
    Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
    Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone undecanoate--oral therapy for male hypogonadism.
    Drug Ther Bull; 1985 Jan; 23(2):7-8. PubMed ID: 3967582
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with Andriol Testocaps--the first Austrian surveillance study on the treatment of late-onset hypogonadism.
    Jungwirth A; Plas E; Geurts P
    Aging Male; 2007 Dec; 10(4):183-7. PubMed ID: 18033627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
    Schubert M; Jockenhövel F
    J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate.
    Saad F; Kamischke A; Yassin A; Zitzmann M; Schubert M; Jockenhel F; Behre HM; Gooren L; Nieschlag E
    Asian J Androl; 2007 May; 9(3):291-7. PubMed ID: 17486268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
    Morgentaler A; Dobs AS; Kaufman JM; Miner MM; Shabsigh R; Swerdloff RS; Wang C
    J Urol; 2008 Dec; 180(6):2307-13. PubMed ID: 18930255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone replacement Up-to-date. LOH and testosterone replacement therapy: clinical application].
    Yasuda M
    Clin Calcium; 2007 Sep; 17(9):1326-33. PubMed ID: 17767020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effect of methyltestosterone and testosterone undecanoate in substitution therapy of hypogonadism].
    Hána V; Marek J; Mellanová A; Hampl R; Stárka L
    Cas Lek Cesk; 1987 Mar; 126(12):369-73. PubMed ID: 3555827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.